← FDA Drug Approvals (Drugs@FDA)
ARFORMOTEROL TARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RITEDOSE CORP · Approved 2022-03-02
Drug application
- FDA Application #
ANDA214736- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ARFORMOTEROL TARTRATE
- Generic name
- ARFORMOTEROL TARTRATE INHALATION SOLUTION
- Active ingredients
- ARFORMOTEROL TARTRATE
- Dosage form
- SOLUTION
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- RITEDOSE CORP
- Manufacturer
- Ritedose Pharmaceuticals, LLC
- First approval
- 2022-03-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown